Biomanufacturing I-O therapeutics in the 21st century
Immuno-Oncology Insights 2021; 2(6), 345–348
10.18609/ioi.2021.041
Published: 29 November 2021
Editorial
Gregory Zarbis-Papastoitsis
“...there is a drive to switch from batch
to continuous processing where efficient
intergradation of the units of operation,
monitoring and control of the process and the
product are achieved.”
